InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,180.74
(
1.03%
)
US TECH 100
17,600.00
(
1.04%
)
Dow Jones
38,852.27
(
0.46%
)
Brent Oil
83.34
(
0.26%
)
Bitcoin
63,319.15
(
-1.06%
)
Post# of 2104
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

staccani

Send PM Follow Ignore
Followers 32
Posts 1683
Boards Moderated 0
Alias Born 01/11/2014

staccani

Re: None

Wednesday, 03/09/2016 4:55:02 PM

Wednesday, March 09, 2016 4:55:02 PM

Post# of 2104
Key points to me: Maybe ph2 LC trial will be changed in ph3 to start 2016 or early 2017 and also Encore PH could warrant Accelerated approval for LC. Overall it is shaping as a potential AA for LC in 2018. Absolutely amazing, we will know more at 6 months LC read out in Q2 2016 (likely April)

http://finance.yahoo.com/news/conatus-pharmaceuticals-reports-2015-financial-210500632.html
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news
Only $200 per official company press release!